Login to Your Account

'Iron Still Hot,' as FDA Vague on Off-Label Speech Freedom

By Randy Osborne
Staff Writer

Friday, February 1, 2013

Late last year, when federal appeals judges threw out the conviction of a former pharma sales rep for off-label marketing after the rep argued that prosecuting him had violated his freedom of speech, the industry could not be sure what it meant for the rest of them.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription